Lefamulin

Formulary Considerations

  • AHC MEDIA,
Infectious Disease Alert 39(374):p 0, June 1, 2020.

The Food and Drug Administration (FDA) recently approved lefamulin for the treatment of adults with community-acquired bacterial pneumonia (CABP).

Copyright © 2020 AHC Media LLC.
View full text|Download PDF